Bunge Global S.A.
NYSE:BGAgricultural Farm Products
-$3.65 today
- Market cap
- $17.91B
- Beta
- 0.62
- P/E (TTM)
- 31.8
- EPS (TTM)
- $3.54
- Dividend yield
- 2.51%
Volume 1.49M
Average 1.70M
BG EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Bunge Global S.A.NYSE: BG
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $1.4B rose 95.0% year over year, ahead of the +13.0% change in trailing-twelve-month EBITDA. Sequentially, it rose 190.8% from the prior quarter. Over 3 fiscal years it compounded at -4.3% a year.
Context
- EBITDA amounted to 3.5% of revenue in FY2025, down 1.1 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $3.47B (+40.8%) for the fiscal year ending Dec 2026, a step up from the +0.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.4B+190.8% QoQ
- Last fiscal yearDec 2025
- $2.47B+0.1% YoY
- LTMJun 2026
- $3.12B+13.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +95.0% | +52.0% | -43.0 pp |
| 1 year | +0.1% | +40.8% | +40.7 pp |
| 3-year CAGR | -4.3% | +20.5% | +24.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 2.47B USD
- Year-over-year change
- +0.1%
- 4-year CAGR
- -6.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.47B | +0.1% |
| FY2024 | 2024-12-31 | 2.46B | -38.7% |
| FY2023 | 2023-12-31 | 4.02B | +43.0% |
| FY2022 | 2022-12-31 | 2.81B | -13.1% |
| FY2021 | 2021-12-31 | 3.23B | — |
EBITDA vs competitors
How BG compares with its peers on the latest reported figures
- BG's LTM Jun 2026 EBITDA of $3.12B is the 2nd highest of the 6 companies compared; the peer median is $585.23M.
- Its year-over-year change of +13.0% is the 3rd highest of 6, against a peer median of +0.1%.
- EBITDA amounts to 3.4% of revenue for BG, versus a peer median of 4.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.84B | +19.0% | -22.9% | 4.7% | |
| LTM Jun 2026 | $3.12B | +13.0% | -4.3% | 3.4% | |
| LTM Feb 2026 | $1.14B | -2.9% | -16.0% | 3.2% | |
| LTM Jun 2026 | $585.23M | +89.4% | -7.3% | 35.5% | |
| LTM Oct 2026 | $542M | -29.5% | -12.0% | 5.2% | |
| LTM Jun 2026 | $341.41M | +0.1% | -5.9% | 3.1% | |
| Peer median (excluding BG) | $585.23M | +0.1% | -12.0% | 4.7% | |
Competitors are the stored peer set for BG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 59.15B | 67.23B | 59.54B | 53.11B | 70.33B |
| Cost of Revenue | 55.79B | 63.55B | 54.7B | 49.72B | 66.92B |
| Gross Profit | 3.36B | 3.68B | 4.85B | 3.39B | 3.41B |
| Gross Margin | 5.7% | 5.5% | 8.1% | 6.4% | 4.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.23B | 1.37B | 1.72B | 1.78B | 2.11B |
| Operating Expenses | 1.23B | 1.37B | 1.72B | 1.78B | 2.11B |
| Depreciation & Amortization | 424M | 408M | 451M | 468M | 703M |
| EBITDA | 3.23B | 2.81B | 4.02B | 2.46B | 2.47B |
| EBITDA Margin | 5.5% | 4.2% | 6.7% | 4.6% | 3.5% |
| Operating Income | 2.13B | 2.31B | 3.13B | 1.62B | 1.3B |
| Operating Margin | 3.6% | 3.4% | 5.3% | 3.0% | 1.8% |
| Interest Income | 48M | 71M | 148M | 163M | 202M |
| Interest Expense | 243M | 403M | 516M | 471M | 628M |
| Other Income / Expenses | 436M | (315M) | (79M) | (93M) | (162M) |
| Income Before Tax | 2.57B | 2B | 3.05B | 1.52B | 1.13B |
| Pre-Tax Margin | 4.3% | 3.0% | 5.1% | 2.9% | 1.6% |
| Income Tax Expense | 398M | 388M | 714M | 336M | 288M |
| Net Income | 2.08B | 1.61B | 2.24B | 1.14B | 816M |
| Net Margin | 3.5% | 2.4% | 3.8% | 2.1% | 1.2% |
| EPS (Basic) | 14.49 | 10.52 | 15.07 | 8.09 | 4.95 |
| EPS (Diluted) | 13.64 | 10.51 | 14.87 | 7.99 | 4.91 |
| Weighted Avg Shares | 141.02M | 153M | 148.8M | 140.54M | 165.04M |
| Weighted Avg Shares (Diluted) | 152.37M | 153M | 150.79M | 142.22M | 166.47M |
Bunge Global S.A.
NYSE:BG
Intrinsic Alpha fair value
Locked
Current Price
$93.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.